Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Potential Pilgrims Aged 56 Years and Older in Turkey
Condition: Healthy Volunteers (Meningococcal Infection) Intervention: Biological: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine (MenACYW conjugate vaccine) Sponsor: Sanofi Pasteur, a Sanofi Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2019 Category: Research Source Type: clinical trials
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Potential Pilgrims Aged 56 Years and Older in Turkey
Condition: Healthy Volunteers (Meningococcal Infection) Intervention: Biological: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine (MenACYW conjugate vaccine) Sponsor: Sanofi Pasteur, a Sanofi Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2019 Category: Research Source Type: clinical trials
Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese
Condition: Vaccine Interventions: Biological: experimental vaccine; Biological: Positive control vaccine 1; Biological: Positive control vaccine 2 Sponsor: Jiangsu Province Centers for Disease Control and Prevention Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2018 Category: Research Source Type: clinical trials
